Ignite Creation Date:
2024-05-06 @ 3:47 PM
Last Modification Date:
2024-10-26 @ 1:57 PM
Study NCT ID:
NCT04755244
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-08-14
First Post:
2021-02-11
Brief Title:
A Study of Evorpacept ALX148 With Venetoclax and Azacitidine for Acute Myeloid Leukemia ASPEN-05
Sponsor:
ALX Oncology Inc
Organization:
ALX Oncology Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-05-05
Start Date Type:
ACTUAL
Primary Completion Date:
2023-05-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-12
Completion Date Type:
ESTIMATED
First Submit Date:
2021-02-11
First Submit QC Date:
February 11 2021
Study First Post Date:
2021-02-16
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-08-11
Last Update Post Date:
2023-08-14
Last Update Post Date Type:
ACTUAL